Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Kondziolka D, Lunsford LD, McLaughlin MR and Flickinger JC (1998) Long-term outcomes after radiosurgery for acoustic neuroma. N Engl J Med 339: 1426–1433
Surveillance, Epidemiology and End Results (SEER) Program Public-Use CD-ROM (1973–1995). National Cancer Institute, DCPC, Surveillance Program, Cancer Statistics Branch, released April 1998, based on the August 1997 submission. Rates are for 1986–1995 data age-adjusted to the 1980 US standard,
Wong FL, Boice JD Jr and Abramson DH (1997) Cancer incidence after retinoblastoma: radiation dose and sarcoma risk. JAMA 278: 1262–1267
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Neurofibromatosis 2, radiosurgery and malignant nervous system tumours. Br J Cancer 82, 998 (2000). https://doi.org/10.1054/bjoc.1999.1030
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.1999.1030
This article is cited by
-
Transition of a vestibular schwannoma to a malignant peripheral nerve sheath tumor with loss of H3K27 trimethylation after radiosurgery—a case report and review of the literature
Neurosurgical Review (2022)
-
Stereotactic radiosurgery for vestibular schwannomas in neurofibromatosis type 2 patients: a systematic review and meta-analysis
Journal of Neuro-Oncology (2022)
-
Comparative clinical and genomic analysis of neurofibromatosis type 2-associated cranial and spinal meningiomas
Scientific Reports (2020)
-
Surgery versus stereotactic radiosurgery for the treatment of multiple meningiomas in neurofibromatosis type 2: illustrative case and systematic review
Neurosurgical Review (2019)
-
Sarcoma in neurofibromatosis 2: case report and review of the literature
Familial Cancer (2019)